Luis Antonio Ruiz-Avila

Cooper Zeltia SA is a private company based in Madrid, Spain.

Transfesa SA provides railroad and logistic services. It offers transport distribution, logistics and auxiliary rail services. The firm also provides outsourcing and courier services. It serves automotive, consumer goods, chemical, steel and public administration industry. The company was founded in 1943 and is headquartered in Madrid, Spain.

Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain.

Zelnova Zeltia SA engages in the production and marketing of chemical products for their domestic, agricultural and industrial use. The firm specializes in insecticides, pesticides, air fresheners, cleaners, disinfectants, and fertilizers. It also offers the supply, contracting, and provision of disinfection, pest control, and deratization services in hospitals and clinics. The company was founded on December 30, 1991 and is headquartered in O Porrino, Spain.

Transfesa Logistics SA operates railroad. It offers transport distribution, logistics, and auxiliary rail and outsourcing services. The company was founded in 1943 and is headquartered in Madrid, Spain.

Antibióticos SA is a Spanish pharmaceutical company that specializes in manufacturing antibiotics and other pharmaceutical preparations. The company is based in León, Spain. Antibióticos was acquired by Black Toro Capital Partners (ES) from Grupo Enerthi on September 17, 2014 for $11.65 million.

GENOMICA SAU provides genetic identification and molecular diagnostic services. Its services include paternity tests, fornsic genetics technological transfers and laboratory genetic identification for criminal investigation. The firm also offers various diagnostic kits and reagents such as CLART PneumoVir, CLINICAL ARRAYS Metabona and CLINICAL ARRAYS-Papillomavirus. It also provides laboratory installation and technical support services and training courses for laboratory, clinical and forensics professionals. The company was founded in 1990 and is headquartered in Madrid, Spain.

Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines.

Bankinter Foundation of Innovation The report focuses on drawing conclusions about the potential socioeconomic impact of the trend discussed, particularly as it affects Spain, in order to communicate pragmatic, down-to-earth knowledge to our target audience. The company is headquartered in Madrid, Spain.

Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain.

l'Associació Catalana d'Empreses de Biotecnologia is business association operating company. It is engaged in promoting health and life sciences activities for biotechnology organizations, business leaders, senior executives, entrepreneurs, investors and journalists. The company was founded in 2006 and is headquartered in Barcelona, Spain.

Fastbase Solutions SL operates an online cancer diagnostic software platform. The company is based in Derio, Spain. Fernando Aguirre has been the CEO of the Spanish company since 2018.

Prospera Biotech SL is a Spanish company that develops innovative solutions for sensitive skin caused by medical treatments and environmental agents. The company is based in Elche, Spain and was founded in 2019. The company's own formulations are free of aggressive agents and suitable for all types of skin. The company specializes in developing cosmetic formulations with innovative neurocosmetics for skin care in sensitive skin with a tendency to atopia, sensitive skins of people who have received chemotherapy and/or radiotherapy, sensitive skins in the intimate parts of the body, and excessive sweating. The CEO is Marta García.

Antalgenics SL is a Spanish biotechnological company that specializes in discovering and developing new bioactive molecules for biomedical and dermocosmetic applications. The company is based in Alicante, Spain. The company offers customized R & D services to design and develop projects according to the client's needs. The company's focus is on developing novel therapeutic leads, primarily for the treatment of psoriatic pruritus and psoriatic comorbidities. Antalgenics was founded in 2015, and the CEO is Philipp Tsolakis.